ACTRN12607000578404尚未招募1 期
A prospective, randomized, multicenter study to evaluate the safety, efficacy and performance of the CardioMind Coronary Stent Systems for treatment of stenotic lesions in small diameter native coronary arteries.
CardioMind0 个研究点目标入组 230 人开始时间: 2007年11月9日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 230
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Suitable candidate for percutaneous coronary intervention (PCI) in a symptomatic native coronary vessel with a reference diameter of 2.0 – 2.75 mm and lesion length < 20 mm. Treatment of one non-target lesion in a separate epicardial vessel is allowed.
排除标准
- •Need for treatment of a second lesion in the target vessel 30 days before or after the index procedure, excessive calcification or tortuosity, presence of thrombus or Thrombolysis in Myocardial Infarction (TIMI) flow < 2, concomitant health conditions (renal insufficiency, recent stroke, myocardial infarction (MI) or gastrointestinal (GI) bleeding), pregnant, unable to comply with antiplatelet therapy, ostial lesions, low coronary reserve.
研究者
相似试验
进行中（未招募）
不适用
A prospective, randomized, multicenter study to evaluate the impact of Darbepoetin alfa in combination with Ferric(III)-Carboxymaltose in comparison to Darbepoetin alfa and Ferric(III)-Carboxymaltose alone in patients with breast cancer and chemotherapy-induced anemia - CIA-StudyThis is a prospective, multicenter, randomized, comparative, parallel group, phase IV study to assess the efficacy and safety of FCM 800mg or Darbepoetin alfa 500µg or the combination of FCM 800mg and Darbepoetin alfa 500µg within 24h last chemotherapy administration in patients with breast cancer and chemotherapy induced anemia.EUCTR2011-001664-22-ATMedizinische Universität Wien - Universitätsklinik für Frauenheilkunde75
招募中
不适用
A Study to evaluate the efficacy and safety of folic acid plus cyanocobalamin plus pyridoxine as an adjuvant to Recombinant Human Epoetin Alpha (r-HuEPO) therapy in patients with anaemia of End stage renal disease (ESRD).CTRI/2010/091/000652Dr Narendra DedhiaParakh HospitalGhatkopar(E)Mumbai - 400 077, Maharashtra50
尚未招募
4 期
A study comparing the effect of intravenous and oral iron supplementation on the quality of life of inflammatory bowel disease patients with iron deficiency without anaemiaHypoferritinaemiaInflammatory Bowel DiseaseACTRN12617000586314Dr Stephen Inns58
招募中
2 期
A multicenter, prospective randomized study to compare vascular healing after deployment of the Abluminal Sirolimus Coated Bio-Engineered Stent (Combo Bio-Engineered Sirolimus Eluting Stent) versus the Everolimus Eluting Stent in patients with Acute Coronary Syndrome by means of Optical Coherence TomographyHeart attack10011082Acute Coronary SyndromeNL-OMON36157OrbusNeich Medical B.V.20
招募中
不适用
Comparison of IVF-ET outcomes with GnRH antagonist started either on stimulation day 1 and 6 vs. conventional GnRH agonist long protocol in patients with polycystic ovary syndromeEndocrine, nutritional and metabolic diseaseKCT0000157Seoul National University Hospital267